Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Inventory Average (2021 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Inventory Average for 5 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 15.37% year-over-year to $1.6 million, compared with a TTM value of $1.6 million through Dec 2025, up 15.37%, and an annual FY2025 reading of $1.6 million, up 49.24% over the prior year.
  • Inventory Average was $1.6 million for Q4 2025 at Neuroone Medical Technologies, up from $1.5 million in the prior quarter.
  • Across five years, Inventory Average topped out at $1.9 million in Q1 2025 and bottomed at $75234.5 in Q3 2021.
  • Average Inventory Average over 5 years is $1.1 million, with a median of $1.3 million recorded in 2023.
  • The sharpest move saw Inventory Average skyrocketed 670.14% in 2022, then decreased 15.37% in 2025.
  • Year by year, Inventory Average stood at $163701.0 in 2021, then surged by 391.17% to $804046.0 in 2022, then surged by 74.83% to $1.4 million in 2023, then decreased by 0.12% to $1.4 million in 2024, then grew by 15.37% to $1.6 million in 2025.
  • Business Quant data shows Inventory Average for NMTC at $1.6 million in Q4 2025, $1.5 million in Q3 2025, and $1.3 million in Q2 2025.